Lv41
430 积分 2024-07-28 加入
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
2小时前
已完结
Covalent targeted radioligands potentiate radionuclide therapy
3个月前
已完结
The Phase II Urokinase-Streptokinase Pulmonary Embolism Trial
3个月前
已关闭
The Phase II Urokinase-Streptokinase Pulmonary Embolism Trial
3个月前
已关闭
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
3个月前
已完结
Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis
3个月前
已完结
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
4个月前
已完结
Trial of Endovascular Thrombectomy for Large Ischemic Strokes
4个月前
已完结
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
4个月前
已完结
皖公网安备34019202002308
